555 LONG WHARF DRIVE, NEW HAVEN, CT
Tenth Amendment to Credit Agreement with Oaktree Fund Administration
Provides Business Update and Reports First Quarter 2026 Financial Results
BioXcel Therapeutics Grants Warrants for 1,353,729 Shares
Other Events
Financial Results, Press Release
BioXcel Therapeutics Enters Registered Direct Offering for 2.48M Shares
BioXcel Therapeutics Enters Milestone and Retention Bonus Agreements
Q1
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload